Molecular Cancer · 2005 · 77 citations · 45 references
Given the ability of C/EBPbeta-2 to confer EGF-independent growth to mammary epithelial cells as well as its capability for disrupting normal epithelial architecture and causing EMT, it is worth considering whether inhibitors which target ErbB family signaling pathways could be less effective in mammary epithelial cells with elevated nuclear C/EBPbeta-2 expression.
45
Ole W. Petersen, Lone Rønnov‐Jessen, Anthony R. Howlett et al. · Proceedings of the National Academy of Sciences · 1992 · 1.1K citations